Stereotaxis, Inc. (STXS)

From the record

Stereotaxis, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Stereotaxis, Inc.'s 8 filed years say what it did: revenue went from $29 million in fiscal 2018 to $32 million in fiscal 2025, up 1.4% a year; it rose in 3 of 7 years; the deepest fall was 24% from fiscal 2021 to fiscal 2023; net income was positive in 1 of 8 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Stereotaxis, Inc. lost about 161 cents for every dollar of shareholders' money, and gross profitability: its products earned about 33 cents per dollar of everything the company owns. Leverage: it owed about 74 cents per dollar of assets, and net share issuance: its share count grew 6.8% over the year (the filed statements).

From the record

Stereotaxis, Inc.'s standing among 24 graded names in its industry family: revenue of $32 million in fiscal 2025 ranks in the bottom 48% by size; a net margin of -66.8% ranks in the bottom 44%; revenue growth of 4.8% a year over the last 3 filed years ranks in the bottom 30% (its annual reports).

From the record

Stereotaxis, Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 8 officers and directors filing in the last fifteen months have been on the record a median of 8.5 years (top 15%); 1 officer or director change was reported on Form 8-K since 2023-11-13, against the 8 people in charge now (top 10%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Stereotaxis, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $13 million against no long-term debt tagged leaves 25.7% of its assets as net cash, top 37% of its family; cash from operations less capital spending is -42.6% of revenue (bottom 37%); a gross margin of 52.7% (bottom 33%); research spending of 29% of revenue (top 25%) (its annual report).

From the record

Stereotaxis, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 4.8% a year over the last three filed years against 1.4% over all 8, speeding up (top 20% of its family); the newest year grew 20.3% (top 37%); research spending grew -3.9% a year (bottom 30%); capital spending grew -66% a year (bottom 2%) (its annual reports). Stereotaxis, Inc. reported 2 product lines in fiscal 2025: Disposables Service and Accessories at $22 million (68%), Systems at $10 million (32%); 2 of 2 grew against the year before (its annual report).

From the record

Stereotaxis, Inc.'s newest year against its own record: revenue of $32 million in fiscal 2025 came in 23% above the $26 million its prior three years' pace pointed to (top 26% of its family); net income of $22 million against a prior three-year average of $21 million (bottom 34%); a net margin of -66.8% against -77.2% before (top 37%) (its annual reports).